Literature DB >> 10477579

The role of the common cytokine receptor gamma-chain in regulating IL-2-dependent, activation-induced CD8+ T cell death.

Z Dai1, A Arakelov, M Wagener, B T Konieczny, F G Lakkis.   

Abstract

IL-2-dependent, activation-induced T cell death (AICD) plays an important role in peripheral tolerance. Using CD8+ TCR-transgenic lymphocytes (2C), we investigated the mechanisms by which IL-2 prepares CD8+ T cells for AICD. We found that both Fas and TNFR death pathways mediate the AICD of 2C cells. Neutralizing IL-2, IL-2R alpha, or IL-2R beta inhibited AICD. In contrast, blocking the common cytokine receptor gamma-chain (gamma c) prevented Bcl-2 induction and augmented AICD. IL-2 up-regulated Fas ligand (FasL) and down-regulated gamma c expression on activated 2C cells in vitro and in vivo. Adult IL-2 gene-knockout mice displayed exaggerated gamma c expression on their CD8+, but not on their CD4+, T cells. IL-4, IL-7, and IL-15, which do not promote AICD, did not influence FasL or gamma c expression. These data provide evidence that IL-2 prepares CD8+ T lymphocytes for AICD by at least two mechanisms: 1) by up-regulating a pro-apoptotic molecule, FasL, and 2) by down-regulating a survival molecule, gamma c.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477579

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs.

Authors:  Geetha Chalasani; Zhenhua Dai; Bogumila T Konieczny; Fady K Baddoura; Fadi G Lakkis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

2.  Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.

Authors:  SangKon Oh; Jay A Berzofsky; Donald S Burke; Thomas A Waldmann; Liyanage P Perera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-07       Impact factor: 11.205

Review 3.  Review article: molecular signals and genetic reprogramming in peripheral T-cell differentiation.

Authors:  A Noble
Journal:  Immunology       Date:  2000-11       Impact factor: 7.397

4.  MHC I Expression Regulates Co-clustering and Mobility of Interleukin-2 and -15 Receptors in T Cells.

Authors:  Gábor Mocsár; Julianna Volkó; Daniel Rönnlund; Jerker Widengren; Péter Nagy; János Szöllősi; Katalin Tóth; Carolyn K Goldman; Sándor Damjanovich; Thomas A Waldmann; Andrea Bodnár; György Vámosi
Journal:  Biophys J       Date:  2016-07-12       Impact factor: 4.033

Review 5.  Bioconjugate Strategies for the Induction of Antigen-Specific Tolerance in Autoimmune Diseases.

Authors:  Chunsong Yu; Jingchao Xi; Meng Li; Myunggi An; Haipeng Liu
Journal:  Bioconjug Chem       Date:  2017-12-06       Impact factor: 4.774

6.  Effect of IL15 on T cell clonality in vitro and in the synovial fluid of patients with rheumatoid arthritis.

Authors:  K Masuko-Hongo; M Kurokawa; T Kobata; K Nishioka; T Kato
Journal:  Ann Rheum Dis       Date:  2000-09       Impact factor: 19.103

Review 7.  Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2020-08-24       Impact factor: 3.199

8.  GB virus C envelope protein E2 inhibits TCR-induced IL-2 production and alters IL-2-signaling pathways.

Authors:  Nirjal Bhattarai; James H McLinden; Jinhua Xiang; Thomas M Kaufman; Jack T Stapleton
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity.

Authors:  Linda A Lieberman; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-06-06

Review 10.  Activation-induced non-responsiveness (anergy) limits CD8 T cell responses to tumors.

Authors:  Matthew F Mescher; Flavia E Popescu; Michael Gerner; Chris D Hammerbeck; Julie M Curtsinger
Journal:  Semin Cancer Biol       Date:  2007-06-23       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.